ArticleFrontiers in immunology2025

Allo-HCT with post-transplant cyclophosphamide in older adults: similar safety and a viable option compared to younger adults.

Gorka Pinedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.